Expertise in

conditions

Yoshinori Ito

Tokyo, JP

Expertise in

conditions

Tokyo, JP

OverviewLocationsClinical Research

Overview

Yoshinori Ito practices in Tokyo, Japan. Mr. Ito is highly rated in 25 conditions, according to our data. His top areas of expertise are Esophageal Cancer, Breast Cancer, Mononucleosis, Mastectomy, and Endoscopy.

His clinical research consists of co-authoring 556 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Tokyo, Japan

Other Locations

Nagakute, Japan

Tokai, 3191195, Japan

Takaidonishi, 1688535, Japan

Kahoku, 9200293, Japan

Hatanodai, 1428666, Japan

Ichinomiya, Japan

Nagoya, 4648547, Japan

3191195, Japan

Itabashi, 1738610, Japan

Okazaki, Japan

Ariake, 1358550, Japan

Takatsuki, Japan

Kurokami, 8608555, Japan

Chuo, 1040045, Japan

Tokai, 3191195, Japan

Yokohama, 2270043, Japan

Karatsu, 8478588, Japan

Tsukiji, 1040045, Japan

Wako, 3510198, Japan

Toyohashi, 4418580, Japan

Kobe, 6500011, Japan

Gifu-shi, Japan

Sayo, 6795148, Japan

Kyoto, 6068507, Japan

Kurashiki, Japan

Shinjuku, 1631328, Japan

Fuchu, 1838509, Japan

Saitama, Japan

Osaka, Japan

Chuo, Japan

Hibarigaoka, 4418580, Japan

Sendai, 9808578, Japan

Shibuya, 1508935, Japan

Kashiwa, 2778581, Japan

Oita, Japan

Shiba, Japan

Toshima, 1708455, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer

Enrollment Status: Active_not_recruiting

Publish Date: April 20, 2025

Intervention Type: Drug

Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy

Study Phase: Phase 3

555 Total Publications

Risk factors and diagnostic indicators for congenital syphilis: a Nationwide retrospective survey.

Journal: Epidemiology and infection

Published: October 22, 2025

View All 555 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ito's expertise for a condition

ConditionClose